Business Trends

Aug 01, 2016
BioPharm International
Congressional partisanship creates noise, but no funding for Zika virus research.
Jul 01, 2016
BioPharm International
CPhI Pharma Awards seek nominations for excellence in biopharma development and manufacturing.
Jun 15, 2016
BioPharm International
By BioPharm International Editors
Biopharmaceutical contractors continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
Jun 15, 2016
BioPharm International
New drug approval policies promote industry growth and injectable contract manufacturing opportunities in China.
Jun 15, 2016
BioPharm International
By BioPharm International Editors
Contract service providers debate the pros and cons of consolidation, accelerated drug approvals, regulatory issues, and the impact of new therapies.
Jun 01, 2016
By BioPharm International Editors
Insight on the new regulatory framework from the China Food and Drug Administration
May 31, 2016
BioPharm sat down with an intellectual property lawyer to examine how companies are protected when they engage in activities where sharing of trade secrets must occur.
May 01, 2016
BioPharm International
Policies for patient access to life-saving therapies must keep pace with biomedical innovation.
Apr 29, 2016
BioPharm International
Immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.
Mar 01, 2016
BioPharm International
Thought leaders tackle drug shortages and biomanufacturing challenges.
native1_300x100
lorem ipsum